Frontiers in Pharmacology (Jun 2023)
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
- Daniel Morales-Cano,
- Daniel Morales-Cano,
- Daniel Morales-Cano,
- Daniel Morales-Cano,
- Daniel Morales-Cano,
- Jose Luis Izquierdo-García,
- Jose Luis Izquierdo-García,
- Jose Luis Izquierdo-García,
- Bianca Barreira,
- Bianca Barreira,
- Bianca Barreira,
- Sergio Esquivel-Ruiz,
- Sergio Esquivel-Ruiz,
- Sergio Esquivel-Ruiz,
- Maria Callejo,
- Maria Callejo,
- Maria Callejo,
- Rachele Pandolfi,
- Rachele Pandolfi,
- Rachele Pandolfi,
- Palmira Villa-Valverde,
- Palmira Villa-Valverde,
- Ignacio Rodríguez,
- Ignacio Rodríguez,
- Angel Cogolludo,
- Angel Cogolludo,
- Angel Cogolludo,
- Jesus Ruiz-Cabello,
- Jesus Ruiz-Cabello,
- Jesus Ruiz-Cabello,
- Francisco Perez-Vizcaino,
- Francisco Perez-Vizcaino,
- Francisco Perez-Vizcaino,
- Laura Moreno,
- Laura Moreno,
- Laura Moreno
Affiliations
- Daniel Morales-Cano
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Daniel Morales-Cano
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Daniel Morales-Cano
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Daniel Morales-Cano
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
- Daniel Morales-Cano
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
- Jose Luis Izquierdo-García
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Jose Luis Izquierdo-García
- Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain
- Jose Luis Izquierdo-García
- Instituto Pluridisciplinar, Universidad Complutense de Madrid, Madrid, Spain
- Bianca Barreira
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Bianca Barreira
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Bianca Barreira
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Sergio Esquivel-Ruiz
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Sergio Esquivel-Ruiz
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Sergio Esquivel-Ruiz
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Maria Callejo
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Maria Callejo
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Maria Callejo
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Rachele Pandolfi
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Rachele Pandolfi
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Rachele Pandolfi
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Palmira Villa-Valverde
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Palmira Villa-Valverde
- ICTS Bioimagen Complutense, Universidad Complutense de Madrid, Madrid, Spain
- Ignacio Rodríguez
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Ignacio Rodríguez
- Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain
- Angel Cogolludo
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Angel Cogolludo
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Angel Cogolludo
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Jesus Ruiz-Cabello
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Jesus Ruiz-Cabello
- Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain
- Jesus Ruiz-Cabello
- Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia San Sebastián, Spain
- Francisco Perez-Vizcaino
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Francisco Perez-Vizcaino
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Francisco Perez-Vizcaino
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Laura Moreno
- Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Laura Moreno
- Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain
- Laura Moreno
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- DOI
- https://doi.org/10.3389/fphar.2023.1228923
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
